article thumbnail

Claims that AI will “revolutionise pharma R&D” are (almost entirely) hype

DrugBaron

Both the cost and the time required for each new drug approval have increased exponentially for decades (aptly tagged ‘Eroom’s Law’, being the inverse of price drops and speed gains in the semiconductor industry). So what about the theoretical basis for the claim that AI can “revolutionise” drug discovery and development?

article thumbnail

Mapping the GenAI Landscape in Pharma R&D

BenchSci

While we have made tremendous progress in drug discovery over the last couple of decades, the process of discovering new drugs is time-consuming, intricate, and costly. Today, the pharmaceutical (pharma) industry is in the midst of a transformative era driven by the advent of Generative AI (GenAI).